Skip to content

Amphastar Pharmaceuticals AMPH Amortization of capitalized software and acquired intangible assets

Amortization of capitalized software and acquired intangible assets at other companies

Halozyme Therapeutics logo
Halozyme TherapeuticsHALO
AbbVie logo
AbbVieABBV
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
HRO
HarrowHROW
Abbott logo
AbbottABT
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX

Other financials

Income statement

See full
Revenue$171.2M+0.4%
Gross profit$70.3M-17.5%
Operating income$13.6M-63.5%
Net income$6.4M-74.6%
EPS (diluted)$0.14-72.5%

Balance sheet

See full
Cash & equivalents$170.9M-6.5%
Total debt$686.6M+5.2%
Total equity$445.5M
Total assets$1.6B+1.3%

Cash flow

See full
Operating cash flow$47.8M+36.4%
CapEx$9.5M-11.1%
Free cash flow$38.3M+57.2%

Valuation

See full
Market cap$927.72M-19.9%
Enterprise value$1.44B-11.3%
P/E11.7×+3.5×
P/S1.3×-0.3×

Profitability

See full
Gross margin47.3%-3.2pp
Operating margin16.2%-10.4pp
Net margin11%-8.4pp
FCF margin18.8%-1.8pp

Returns & leverage

See full
Return on equity14.7%
Debt / equity0.2×
Current ratio3.9×+0.9×

Where this comes from

Reported directly by Amphastar Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: Amphastar Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Amphastar Pharmaceuticals's amortization of capitalized software and acquired intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Amphastar Pharmaceuticals's amortization of capitalized software and acquired intangible assets?
Amphastar Pharmaceuticals (AMPH) reported amortization of capitalized software and acquired intangible assets of $6.27M in Q1 2026.
How has Amphastar Pharmaceuticals's amortization of capitalized software and acquired intangible assets changed year-over-year?
Amphastar Pharmaceuticals's amortization of capitalized software and acquired intangible assets increased by 0.5% year-over-year, from $6.24M to $6.27M.
What is the long-term trend for Amphastar Pharmaceuticals's amortization of capitalized software and acquired intangible assets?
Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's amortization of capitalized software and acquired intangible assets has grown at a 119.9% compound annual growth rate (CAGR), from $1.07M to $25.05M.